본문 바로가기

Talk talk talk

OCGN conference call at 18, Mar

반응형

https://finance.yahoo.com/news/ocugen-provides-business-full-2020-113000655.html

Ocugen Provides Business Update and Full Year 2020 Financial Results

Conference Call and Webcast Today at 8:30 a.m. ET COVID-19 vaccine candidate, COVAXIN™, demonstrates efficacy of 81% in Phase 3 interim resultsEmergency Use Authorization pathway with U.S. regulatory authorities in development for COVAXIN™European Comm

finance.yahoo.com


https://twitter.com/stoltzystonks/status/1372536024174321665?s=21

StoltzyStonks on Twitter

“$OCGN webcast is now over, quick summary: - In talks to receive US EUA approval - Primary focus is helping to vaccinate children - Waiting for phase 3 trial data to be officially released”

twitter.com

 

반응형